HIV/AIDS Topics Coverage of 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy -- better known as ICAAC -- in San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, and cancer caused by HPV, along with a gamut of other infectious diseases including influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section
9/11/12
AAP Says Infant Circumcision Benefit Outweighs Risk, but Doesn't Recommend for All
- Details
- Category: HIV Prevention
- Published on Thursday, 30 August 2012 00:00
- Written by Press Release
The American Academy of Pediatrics (AAP) this week announced that a comprehensive review of medical evidence has shown that circumcision of newborn boys confers more advantages -- including reduced risk of HIV and other sexually transmitted diseases -- than drawbacks. However, the organization did not recommend that all baby boys should undergo the procedure, but rather that the decision should be made by parents. 
AIDS 2012: NIH to Test Dapivirine Vaginal Ring for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Friday, 03 August 2012 00:00
- Written by Press Release
A Phase 3 study will soon be underway to test a vaginal ring containing the NNRTI dapivirine (TMC120) as a potential new woman-controlled HIV prevention method, the National Institutes of Health announced at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC.
CDC Issues PrEP Guidance for Prevention of Heterosexual HIV Transmission
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 14 August 2012 00:00
- Written by Press Release
The U.S. Centers for Disease Control and Prevention (CDC) last week issued provisional guidance for the use of tenofovir/emtricitabine (Truvada) pre-exposure prophylaxis -- better known as PrEP -- to prevent heterosexual HIV transmission, adding to earlier guidelines issued for gay and bisexual men. The recommendations stress the importance of a negative HIV test prior to starting PrEP and a comprehensive package of prevention support.
AIDS 2012: HIV PrEP: Toxic Lifelong Therapy or Effective Niche Prevention? [VIDEO]
- Details
- Category: HIV Prevention
- Published on Wednesday, 01 August 2012 00:00
- Written by Gregory Fowler
Pre-exposure prophylaxis -- better known as PrEP -- for HIV prevention remains a controversial issue. At the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC, Julio Montaner and Kenneth Mayer described new IAPAC PrEP guidelines and responded to concerns of a skeptical journalist.
Web Design and Development by